Latest AI and machine learning research in chemotherapy for healthcare professionals.
BACKGROUND: Neoadjuvant chemoradiotherapy is a standard treatment for locally advanced rectal cancer...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death globally, characterized by...
Neoadjuvant therapy has been widely used in breast cancer, but treatment response varies among indiv...
OBJECTIVES: This study aimed to develop a pretreatment CT-based multichannel predictor integrating d...
This study developed a machine learning model for predicting the presence of tertiary lymphoid struc...
HER2-low positivity is reported to play substantial role in neoadjuvant chemotherapy for breast canc...
The stability and therapeutic efficacy of antibody-drug conjugates (ADCs) are critically determined ...
Cholangiocarcinoma (CCA) is a prevalent bile duct cancer with limited treatment options. Cisplatin-b...
In recent years, there has been a headlong rush into the use of prostate-specific membrane antigen (...
Recent decades have seen great advances in the diagnosis and management of rectal cancer, and magnet...
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the ...
Self-propelled nano- and micromachines have immense potential as autonomous seek-and-act devices in ...
UNLABELLED: Spinal tumors represent 15% of all central nervous system malignancies, with intramedull...
BACKGROUND: Pathological complete response (pCR) to neoadjuvant systemic therapy (NAST) is an establ...
Use of highly purified antigens to improve vaccine safety has led to reduced immunogenicity and effi...
Vaccines have had a major impact on the control of infectious disease, most recently by helping to c...
Hypoxia arises in most solid tumors with insufficient blood flow, which hinders the delivery and eff...
BACKGROUND: Gastric interoception (i.e., the perception of gastrointestinal signals such as hunger, ...
Cancer remains one of the most deadly diseases in the world, requiring constant growth and improveme...
Over the past two decades, non-small cell lung cancer (NSCLC) has witnessed encouraging advancements...
Metastatic hepatic carcinoma (MHC) remains a lethal disease, with a 5-year survival rate of around 1...